Increased serum and/or plasma levels of HMGB1 have been reported in several human autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis [13–15], indicating the involvement of HMGB1 in the pathogenesis of these autoimmune diseases. This evidence concerns the gene HMGB1 and autoimmune disease.